Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-5-2
pubmed:abstractText
To assess the safety and evaluate the effects of repeated treatments with botulinum toxin type A (BTX-A) on functional disability, quality of life (QOL), and muscle tone of patients with upper-limb poststroke spasticity, as well as its effect on caregivers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1532-821X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
799-806
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18452724-Activities of Daily Living, pubmed-meshheading:18452724-Botulinum Toxins, Type A, pubmed-meshheading:18452724-Caregivers, pubmed-meshheading:18452724-Disability Evaluation, pubmed-meshheading:18452724-Dose-Response Relationship, Drug, pubmed-meshheading:18452724-Female, pubmed-meshheading:18452724-Humans, pubmed-meshheading:18452724-Injections, Intramuscular, pubmed-meshheading:18452724-Male, pubmed-meshheading:18452724-Middle Aged, pubmed-meshheading:18452724-Muscle, Skeletal, pubmed-meshheading:18452724-Muscle Spasticity, pubmed-meshheading:18452724-Muscle Tonus, pubmed-meshheading:18452724-Neuromuscular Agents, pubmed-meshheading:18452724-Prospective Studies, pubmed-meshheading:18452724-Quality of Life, pubmed-meshheading:18452724-Stroke, pubmed-meshheading:18452724-Treatment Outcome, pubmed-meshheading:18452724-Upper Extremity
pubmed:year
2008
pubmed:articleTitle
Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
pubmed:affiliation
Kessler Medical Rehabilitation Research and Education Center, West Orange, NJ, USA. eelovic@kmrrec.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study